arrow
H

Hiroyuki Uchida

keio university school of medicine
H指数:52
被引数:1.2万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Cross-Cultural Comparison of Perceived Stigma in Major Depressive Disorder: The Role of Spiritual Well-Being, Resilience, and Quality of Life in Austria and Japan

跨文化比较中重度抑郁障碍患者感知污名:灵性健康、心理韧性和生活质量在奥地利和日本的作用

2026-08-060
PRE
High prevalence of tau pathologies in late-onset psychosis: A PET study

晚发性精神病中tau病理的高患病率:一项PET研究

2026-08-030
OA
Global Perspectives on CNS Drug Innovation: Achievements, Barriers, and Priorities for the Next Decade

全球中枢神经系统药物创新展望:成就、障碍及未来十年的优先事项

2026-05-070
OA
Stereotypical diagnostic bias for alcohol-induced ketoacidosis could lead to death: Normal blood sugar levels in SGLT2 blocker-induced severe diabetic ketoacidosis

酒精诱导性酮症酸中毒的刻板诊断偏倚可能导致死亡:SGLT2抑制剂诱导的严重糖尿病酮症酸中毒中的正常血糖水平

2025-12-290
OAAI
Associations of neuromelanin in the substantia nigra with antipsychotic response in schizophrenia

黑质中神经黑色素与精神分裂症抗精神病药物反应的关系

2025-11-070
PRE
A longitudinal PET study on changes in brain norepinephrine transporter availability following duloxetine treatment in major depressive disorder

一项关于度洛西汀治疗在重度抑郁症中脑去甲肾上腺素转运体可利用性变化的长时程正电子发射断层扫描研究

2025-10-010
OAAI
Decreased long-interval intracortical inhibition in the dorsolateral prefrontal cortex using TMS-EEG in patients with treatment-resistant depression

使用TMS-EEG发现,难治性抑郁症患者背外侧前额叶皮层的长间隔皮层内抑制降低。

2025-09-090
PRE
The association between amygdalar volume changes and depressive symptom improvements after repeated ketamine infusion in treatment-resistant depression: a double-blind, randomized, placebo-controlled trial with the following open-label study

杏仁核体积变化与重复性氯胺酮输注后难治性抑郁症患者抑郁症状改善之间的关联:一项双盲、随机、安慰剂对照试验及一项开放标签研究

2025-08-140
PRE
Differentiation between bipolar disorder and major depressive disorder based on AMPA receptor distribution

基于AMPA受体分布的双相障碍与重度抑郁障碍的鉴别

2025-08-070
OA